Cornell University - I-Corps Hub: Interior Northeast

News

Ascribe Closes $12 Million Series A Financing to Advance Next-Gen Natural Crop Protection https://www.in-icorps.org/wp-content/uploads/2026/01/ourtechnology.jpeg 1280 720 I-Corps Hub: Interior Northeast I-Corps Hub: Interior Northeast https://www.in-icorps.org/wp-content/uploads/2026/01/ourtechnology.jpeg January 27, 2026 February 3, 2026

Reese Abrahamson
January 27, 2026
No Comments

Ascribe Closes $12 Million Series A Financing to Advance Next-Gen Natural Crop Protection

Ascribe Bioscience, an Ithaca, NY–based agricultural technology company, has closed a $12 million Series A financing round to support the commercial launch of its flagship biofungicide, Phytalix®.

OWiC Technologies Wins $2.3M NIH Fast-Track SBIR Award https://www.in-icorps.org/wp-content/uploads/2025/12/0413_microsensor-1.jpg 670 893 I-Corps Hub: Interior Northeast I-Corps Hub: Interior Northeast https://www.in-icorps.org/wp-content/uploads/2025/12/0413_microsensor-1.jpg December 22, 2025 February 3, 2026

Reese Abrahamson
December 22, 2025
No Comments

OWiC Technologies Wins $2.3M NIH Fast-Track SBIR Award

I-Corps alumni company OWiC Technologies has been awarded a $2.35 million Fast-Track SBIR grant from the National Institutes of Health’s National Institute of General Medical Sciences (NIGMS).

A detailed arteriogram of the brain, showing the major arteries and their branches with contrast dye flowing through, highlighting possible aneurysms.

Neuralenz Secures $500k NINDS STTR Award https://www.in-icorps.org/wp-content/uploads/2024/12/AdobeStock_1003166805-Large.jpeg 1280 731 I-Corps Hub: Interior Northeast I-Corps Hub: Interior Northeast https://www.in-icorps.org/wp-content/uploads/2024/12/AdobeStock_1003166805-Large.jpeg December 16, 2024 February 6, 2025

icorpshubstg
December 16, 2024
No Comments

Neuralenz Secures $500k NINDS STTR Award

In September, the National Institutes of Health’s National Institute of Neurological Disorders and Stroke (NINDS) awarded Neuralenz a $500k Phase I STTR grant for developing a new, non-invasive measurement of cerebral blood flow that could enable doctors to rapidly detect neurological damage and treat it more accurately.